Angiotensin and cytoskeletal proteins: Role in vascular remodeling

Current Hypertension Reports

Volumn 4, Issue 1, 2002, Pages 63-70

  Wesselman, Jos P M ^a   De Mey, Jo G R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN RECEPTOR; CYTOSKELETON PROTEIN; RENIN; RHO GUANINE NUCLEOTIDE BINDING PROTEIN;

BLOOD; BLOOD VESSEL; HUMAN; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANGIOTENSIN II; BLOOD VESSELS; CYTOSKELETAL PROTEINS; HUMANS; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTORS, ANGIOTENSIN; RENIN; RHO GTP-BINDING PROTEINS; SIGNAL TRANSDUCTION;

EID: 0036482321     PISSN: 15226417     EISSN: 15343111     Source Type: Journal    
DOI: 10.1007/s11906-002-0055-9     Document Type: Article

References (79)

1. Mulvany MJ, Baumbach GL, Aalkjaer C, et al: Vascular remodeling. Hypertension 1996, 28:505-506.
2. VanWijk MJ, Kublickiene K, Boer K., et al.: Vascular function in preeclampsia. Cardiovasc Res 2000, 47:38-48.
3. Pratt RE: Angiotensin II and the control of cardiovascular structure. J Am Soc Nephrol 1999, 10(SUPPL. 11):S120-S128.
4. Borland JAA, Chester AH, Yacoub MH: The renin angiotensin system in bypass graft surgery. Curr Opin Cardiol 2000, 15:371-377.
5. Park JB, Schiffrin EL: Effects of antihypertensive therapy on hypertensive vascular disease. Curr Hypertens Rep 2000, 2:280-288.
6. Dzau VJ: Tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001, 37:1047-1052.
7. Bardy N, Merval R, Benessiano J., et al.: Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res 1996, 79:70-78.
8. Rosendorff C: The renin-angiotensin system and vascular hypertrophy. J Am Coll Cardiol 1996, 28:803-812.
9. Morgan T, Craven C, Ward K: Human spiral artery renin-angiotensin system. Hypertension 1998, 32:683-687.
10. Shiota N, Okunishi H, Fukamizu A., et al.: Activation of two angiotensin-generating systems in the balloon-injured artery. FEBS Lett 1993, 323:239-242.
11. Padmanabhan N, Jardine AG, McGrath J.C., et al.: Angiotensinconverting enzyme-independent contraction to angiotensin I in human resistance arteries. Circulation 1999, 99:2914-2920.
12. Takai S, Yuda A, Jin D., et al.: Inhibition of chymase reduces vascular proliferation in dog grafted veins. FEBS Lett 2000, 467:141-144.
13. Kranzhofer R, Schmidt J, Pfeiffer C.A., et al.: Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 1999, 19:1623-1629.
14. Tummala PE, Chen XL, Sundell C.L., et al.: Angiotensin II induces vascular cell adhesion molecule-1 expression in rat vasculature. A potential link between the renin-angiotensin system and atherosclerosis. Circulation 1999, 100:1223-1229.
15. Govindarajan G, Eble DM, Lucchesi P.A., et al.: Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells. Circ Res 2000, 87:710-716.
16. Haendeler J, Berk BC: Angiotensin II mediated signal transduction. Important role of tyrosine kinases. Regul Pept 2000, 95:1-7.
17. Kim S, Iwao H: Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev 2000, 52:11-34.
18. Ruiz-Ortega M., Lorenzo O, Ruperez M., et al.: Angiotensin II activates nuclear transcription factor (B through AT1 and AT2 in vascular smooth muscle cells. Molecular mechanisms. Circ Res 2000, 86:1266-1272.
19. Eguchi S, Dempsey PJ, Frank G.D., et al.: Activation of MAPKs by angiotensin II in vascular smooth muscle cells. Metallopro-tease-dependent EGF receptor activation is required for activation of ERK and p38 MAPK but not for JNK. J Biol Chem 2001, 276:7957-7962.
20. El Mabrouk M., Touyz RM, Schiffrin EL: Differential ANG II-induced growth activation pathways in mesenteric artery smooth muscle cells from SHR. Am J Physiol 2001, 281:H30-H39.
21. Touyz RM, He G, El Mabrouk M, Schiffrin EL: p38 Map kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY. Hypertension 2001, 37:574-580.
22. Touyz RM, He G, Wu X.H., et al.: Src is an important mediator of extracellular signal-regulated kinase 1/2-dependent growth signaling by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients. Hypertension 2001, 38:56-64.
23. Ushio-Fukai M., Alexander RW, Akers M, et al: Angiotensin II receptor coupling to phospholipase D is mediated by the βγ subunits of heterotrimeric G proteins in vascular smooth muscle cells. Mol Pharmacol 1999, 55:142-149.
24. Touyz RM, Wu XH, He G, et al: Role of c-Src in the regulation of vascular contraction and Ca2+ signaling by angiotensin II in human vascular smooth muscle cells. J Hypertens 2001, 19:441-449.
25. Gerthoffer WT, Gunst SJ: Focal adhesion and small heat shock proteins in the regulation of actin remodeling and contractility in smooth muscle. J Appl Physiol 2001, 91963-972.
26. Meloche S, Landry J, Huot J., et al.: p38 MAP kinase pathway regulates angiotensin II-induced contraction of rat vascular smooth muscle. Am J Physiol 2000, 279:H741-H751.
27. Touyz RM, Schiffrin EL: Ang II-stimulated superoxide production is mediated via phospholipase D in human vascular smooth muscle cells. Hypertension 1999, 34:976-982.
28. Griendling KK, Ushio-Fukai M: Reactive oxygen species as mediators of angiotensin II signaling. Regul Pept 2000, 91:21-27.
29. Viedt C, Soto U, Krieger-Brauer HI, et al.: Differential activation of mitogen-activated protein kinases in smooth muscle cells by angiotensin II. Involvement of p22phox and reactive oxygen species. Arterioscler Thromb Vasc Biol 2000, 20:940-948.
30. Lassegue B, Sorescu D, Szocs K., et al.: Novel gp91phox homologues in vascular smooth muscle cells. Nox1 mediates angiotensin II-induced superoxide formation and redox - sensitive signaling pathways. Circ Res 2001, 88:888-894.
31. Lavigne MC, Malech HL, Holland S.M., et al.: Genetic demonstration of p47phox-dependent superoxide anion production in murine vascular smooth muscle cells. Circulation 2001, 104:79-84.
32. Wang HD, Xu S, Johns D.G., et al.: Role of NADPH oxidase in the vascular hypertrophic and oxidative stress response to angiotensin II in mice. Circ Res 2001, 88:947-953.
33. Rajagopalan S, Meng XP, Ramasamy S, et al: Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability. J Clin Invest 1996, 98:2572-2579.
34. Eguchi S, Inagami T: Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase. Regul Pept 2000, 9113-20.
35. Johns DG, Dorrance AM, Leite R, et al: Novel signaling pathways contributing to vascular changes in hypertension. J Biomed Sci 2000, 7:431-443.
36. Heeneman S, Haendeler J, Saito Y., et al.: Angiotensin II induces transactivation of two different populations of the platelet-derived growth factor beta receptor. Key role for the p66 adaptor protein Shc. J Biol Chem 2000, 275:15926-15932.
37. Kim S, Zhan Y, Izumi Y., et al.: In vivo activation of rat aortic platelet-derived growth factor and epidermal growth factor receptors by angiotensin II and hypertension. Arterioscler Thromb Vasc Biol 2000, 20:2539-2545.
38. Moreau P, d'Uscio LV, Shaw S, et al: Angiotensin II increases tissue endothelin and induces vascular hypertrophy. Reversal by ETA-receptor antagonist. Circulation 1997, 96:1593-1597.
39. Barton M, Shaw S, d'Uscio LV, et al: Angiotensin II increases vascular and renal endothelin-1 and functional endothelin converting enzyme activity in vivo: role of ETA receptors for endothelin regulation. Biochem Biophys Res Commun 1997, 238:861-865.
40. Suter C, Coote JH: Intrathecally administered angiotensin II increases sympathetic activity in the rat. J Auton Nerv Syst 1987, 19:31-37.
41. Parker SB, Wade SS, Prewitt RL: Pressure mediates angiotensin II-induced arterial hypertrophy and PDGF-A expression. Hypertension 1998, 32:452-458.
42. Schiffrin EL, Park JB, Intengan H.D., et al.: Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losar-tan. Circulation 2000, 101:1653-1659.
43. Rizzoni D, Porteri E, Piccoli A., et al.: Effects of losartan and enalapril on small artery structure in hypertensive rats. Hypertension 1998, 32:305-310.
44. Rizzoni D, Porteri E, Guefi D., et al.: Cellular hypertrophy in subcutaneous small arteries of patients with renovascular hypertension. Hypertension 2000, 35:931-935.
45. Struijker-Boudier HAJ, van Essen H, Fazzi G, et al: Disproportional arterial hypertrophy in hypertensive mRen-2 transgenic rats. Hypertension 1996, 28:779-784.
46. Andresen BT, Jackson EK, Romero GG: Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR. Hypertension 2001, 37:635-639.
47. Bouillier H, Samain E, Rucker-Martin C, et al.: Effect of extracellular matrix elements on angiotensin II-induced calcium release in vascular smooth muscle cells from normotensive and hypertensive rats. Hypertension 2001, 37:1465-1472.
48. De Mey J.G., Hilgers RH, Aartsen W.M., et al.: Altered flow-induced remodeling in tissue angiotensin-converting enzyme deficient mice [abstract]. J Vasc Res 2001, 38(SUPPL. 1):9.
49. Warnholtz A, Nickenig G, Schulz E., et al.: Increased NADH-oxi-dase-mediated superoxide production in the early stages of atherosclerosis. Evidence for involvement of the renin-angiotensin system. Circulation 1999, 99:2027-2033.
50. Diet F, Pratt RE, Berry G.J., et al.: Increased accumulation of tissue ACE in human atherosclerotic coronary artery disease. Circulation 1996, 94:2756-2767.
51. Janmey PA: The cytoskeleton and cell signaling: component localization and mechanical coupling. Physiol Rev 1998, 78:763-781.
52. Henrion D, Terzi F, Matrougui K., et al.: Impaired flow-induced dilation in mesenteric resistance arteries from mice lacking vimentin. J Clin Invest 1997, 100:2909-2914.
53. Laufs U, Endres M, Stagliano N., et al.: Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest 2000, 106:15-24.
54. Nakamura M, Sunagawa M, Kosugi T., et al.: Actin filament disruption inhibits L-type Ca2+ channel current in cultured vascular smooth muscle cells. Am J Physiol 2000, 279:C480-C487.
55. Sun D, Huang A, Sharma S., et al.: Endothelial microtubule disruption blocks flow-dependent dilation of arterioles. Am J Physiol 2001, 280:H2087-H2093.
56. Platts SH, Falcone JC, Holton W.T., et al.: Alteration of microtubule polymerization modulates arteriolar vasomotor tone. Am J Physiol 1999, 277:H100-H106.
57. Paul RJ, Bowman PS, Kolodney MS: Effects of microtubule disruption on force, velocity, stiffness and [Ca2+]i in porcine coronary arteries. Am J Physiol 2000, 279:H2493-H2501.
58. Bakker ENTP, van der Meulen ET, Spaan JAE, et al.: Organoid culture of cannulated rat resistance arteries: effect of serum factors on vasoactivity and remodeling. Am J Physiol 2000, 278:H1233-H1240.
59. Helmke BP, Goldman RD, Davies PF: Rapid displacement of vimentin intermediate filaments in living endothelial cells exposed to flow. Circ Res 2000, 86:745-752.
60. Schiffers PMH, Henrion D, Boulanger C.M., et al.: Altered flow-induced arterial remodeling in vimentin-deficient mice. Arterioscler Thromb Vasc Biol 2000, 20:611-616
61. Samain E, Bouillier H, Perret C., et al.: ANG II-induced Ca2+ increase in smooth muscle cells from SHR is regulated by actin and microtubule networks. Am J Physiol 1999, 277:H834-H841.
62. Walpola PL, Gotlieb AI, Langille BL: Monocyte adhesion and changes in endothelial cell number, morphology, and F-actin distribution elicited by low shear stress in vivo. Am J Pathol 1993, 142:1392-1400.
63. Colangelo S, Langille BL, Steiner G, et al: Alterations in endothelial F-actin microfilaments in rabbit aorta in hypercholesterolemia. Arterioscler Thromb Vasc Biol 1998, 18:52-56.
64. Turner CE, Pietras KM, Taylor D.S., et al.: Angiotensin II stimulation of rapid paxillin tyrosine phosphorylation correlates with the formation of focal adhesions in rat aortic smooth muscle cells. J Cell Sci 1995, 108:333-342.
65. Ishida T, Ishida M, Suero J., et al.: Agonist-stimulated cytoskele-tal reorganization and signal transduction at focal adhesions in vascular smooth muscle cells require c-Src. J Clin Invest 1999, 103:789-797.
66. Palazzo AF, Cook TA, Alberts A.S., et al.: mDia mediates Rho-regulated formation and orientation of stable microtubules. Nat Cell Biol 2001, 3:723-729.
67. Meriane M, Mary S, Comunale F., et al.: Cdc42Hs and Rac1 GTPases induce the collapse of the vimentin intermediate filament network. J Biol Chem 2000, 275:33046-33052.
68. Sah VP, Seasholtz TM, Sagi S.A., et al.: The role of Rho in G protein-coupled receptor signal transduction. Ann Rev Pharmacol Toxicol 2000, 40:459-489.
69. van Nieuw Amerongen GP, van Hinsbergh VWM: Cytoskeletal effects of Rho-like small guanine nucleotide-binding proteins in the vascular system. Arterioscler Thromb Vasc Biol 2001, 21:300-311.
70. Uehata M, Ishizaki T, Satoh H., et al.: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 1997, 389:990-994.
71. Chrissobolis S, Sobey CG: Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension. Comparison with protein kinase C. Circ Res 2001, 88:774-779.
72. Mukai Y, Shimokawa H, Matoba T., et al.: Involvement of Rho-kinase in hypertensive vascular disease: a novel therapeutic target in hypertension. Faseb J 2001, 15:1062-1064.
73. Numaguchi K, Eguchi S, Yamakawa T., et al.: Mechanotransduction of rat aortic vascular smooth muscle cells requires RhoA and intact actin filaments. Circ Res 1999, 85:5-11.
74. Li S, Chen BPC, Azuma N, et al: Distinct roles for the small GTPases Cdc42 and Rho in endothelial responses to shear stress. J Clin Invest 1999, 103:1141-1150.
75. Funakoshi Y, Ichiki T, Shimokawa H., et al.: Rho-kinase mediates angiotensin II-induced monocyte chemoattractant protein-1 expression in rat vascular smooth muscle cells. Hypertension 2001, 38:100-104.
76. Takeda K, Ichiki T, Tokunou T., et al.: Critical role of Rho-kinase and MEK/ERK pathways for angiotensin II - induced plasminogen activator inhibitor type-1 gene expression. Arterioscler Thromb Vasc Biol 2001, 21868-873.
77. Morishige K, Shimokawa H, Eto Y., et al.: Adenovirus-mediated transfer of dominant-negative Rho-kinase induces a regression of coronary arteriosclerosis in pigs in vivo. Arterioscler Thromb Vasc Biol 2001, 21548-554.
78. Shimokawa H, Morishige K, Miyata K., et al.: Long-term inhibition of Rho-kinase induces a regression of arteriosclerotic coronary lesions in a porcine model in vivo. Cardiovasc Res 2001, 51169-177.
79. Eto Y, Shimokawa H, Hiroki J., et al.: Gene transfer of dominant negative Rho kinase suppresses neointimal formation after balloon injury in pigs. Am J Physiol 2000, 278:H1744-H1750.